Ignite Creation Date:
2025-12-24 @ 6:25 PM
Ignite Modification Date:
2026-04-11 @ 3:43 AM
Study NCT ID:
NCT00753168
Status:
COMPLETED
Last Update Posted:
2009-01-07
First Post:
2008-09-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma
Sponsor:
Othera Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
OT-730-C01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Alison Brown
Old Organization:
Othera Pharmaceuticals, Inc.